Avestha Gengraine Technologies Pvt. Ltd., India's leading Biotechnology and Bioinformatics Company has strengthened its senior management team by putting in place its key executives to oversee its three strategic business units, Avesthagen Research-RPO, Nutraceuticals-Avgen Inc., and Agbiotech-AQUAS.

J. Rajagopalan has recently been appointed chief finance officer and general manager, Administration for the whole company. He has over 25 years of management experience in several senior roles covering Finance, Legal and Administration, at Britannia Industries Ltd.

Also Dr. Gilles Amsallem has been appointed as the chief operating officer, with responsibilities of driving all operations within the company. Dr. Amsallem has more than 20 years of leadership experience in the development of international Biotechnology companies.

The company has appointed -Dr. K.R. Rajyashri, Director of Research Process Outsourcing-RPO; Dr.Rajesh Ullanat, Vice President, Biotherapeutics; Vinay Konaje, Vice President, Business Development;. Pierre Socha, Vice President, International Business Development and European Representative based in the UK -in Research-RPO.

The new officials who were appointed in Nutraceuticals-Avesthagen Inc are Dr. Victor Moreno, Head Nutraceuticals based in San Diego, California; Intekhab, Vice President, Business Development; Dhruv Dayal, Sr. Business Development; Dr. Ashok Mundrigi, Head-Cell Assay Group.